SB
Stony Brook MedicineRadiation Oncology Residency Program
Stony Brook, NY
Continued AccreditationACGME #4303500146University
Stony Brook Medicine is an ACGME-accredited university-based Radiation Oncology residency program in Stony Brook, NY. It has 1 PGY-1 position per year and approximately 4 residents in training. MatchPath compiles this profile from ACGME, FREIDA, and NRMP public data; IMG acceptance, J-1 and H-1B visa sponsorship, USMLE Step 2 CK requirements, and PGY-1 salary are available on the full profile.
Frequently Asked Questions
- Where is Stony Brook Medicine located?
- Stony Brook Medicine is located in Stony Brook, NY.
- What type of program is Stony Brook Medicine?
- Stony Brook Medicine is a university-based residency program.
- Is Stony Brook Medicine ACGME-accredited?
- Yes — Stony Brook Medicine holds continued ACGME accreditation.
- How many residents are at Stony Brook Medicine?
- Stony Brook Medicine has approximately 4 residents in training.
- Does Stony Brook Medicine accept International Medical Graduates (IMGs)?
- Stony Brook Medicine is a US Radiation Oncology residency program, based in Stony Brook, NY. IMG acceptance varies by year and program. Sign in to MatchPath to see Stony Brook Medicine's IMG acceptance rate, visa sponsorship, and USMLE Step 2 CK cutoff where reported.
- Does Stony Brook Medicine sponsor J-1 or H-1B visas?
- Visa sponsorship is set by each program and its sponsoring institution. Sign in to MatchPath to see whether Stony Brook Medicine sponsors J-1 or H-1B visas for IMG applicants.
- What USMLE Step 2 CK score does Stony Brook Medicine require?
- Step 2 CK expectations differ by specialty and program. MatchPath shows the Step 2 CK cutoff Stony Brook Medicine reports — sign in to view it and compare it against your score.
- What is the resident salary at Stony Brook Medicine?
- Resident salary is set by the sponsoring institution and rises each training year, from PGY-1 through completion. Sign in to MatchPath to see Stony Brook Medicine's reported salary where available.